Literature DB >> 31559308

Investigation of multicellular tumor spheroids enriched for a cancer stem cell phenotype.

Tetiana Herheliuk1,2, Olena Perepelytsina1, Andriy Ugnivenko1, Lyudmila Ostapchenko2, Mykhailo Sydorenko1.   

Abstract

BACKGROUND: Cancer stem cells (CSCs) provide self-renewal of the tumor after radiation and chemotherapy. These cells are important during tumor development. The in vitro model of avascular tumor that enriched of cells with stem like characteristics is critical to understanding of the role CSCs in the tumor.
METHODS: Cell viability was evaluated by MTT assay. The expression of cancer stem cells markers (CD133, CD44, CD24 and bmi-1) in 2D cell culture and multicellular tumor spheroids (MCTS) of MCF-7 cells was evaluated. The Stemi2000 software AxioVisionRed 4.7 was used for image processing. The volume of spheroids was calculated by Bjerkvig formula.
RESULTS: The highest expression of CD133, CD44, CD24 and bmi-1 receptors was detected in MCTS, enriched with cancer stem cells (eMCTS). Cell aggregates of eMCTS culture were returned from suspension to adhesive conditions. It was found that the cells of the MCTS surface layers were enriched with CD133, CD44, CD24, bmi-1, EpCAM, vim markers, but not adherent cells. eMCTS are less sensitive to anticancer drugs (cisplatin, methotrexate and doxorubicin), than adhesive cell culture and MCTS cultured under standard conditions in a complete nutrient medium (P<0.05).
CONCLUSIONS: We observed that eMCTS population possesses aggressive phenotypic characteristics such as invasion, cancer stem cell markers and chemoresistance. eMCTS model could improve the screening efficiency of therapeutical agents against CSCs.

Entities:  

Keywords:  MCF-7 cells; cancer stem cells (CSCs); cisplatin; doxorubicin; methotrexate; multicellular tumor spheroids (MCTS)

Year:  2019        PMID: 31559308      PMCID: PMC6737404          DOI: 10.21037/sci.2019.06.07

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN: 2306-9759


  47 in total

1.  Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation.

Authors:  Anna V Molofsky; Ricardo Pardal; Toshihide Iwashita; In-Kyung Park; Michael F Clarke; Sean J Morrison
Journal:  Nature       Date:  2003-10-22       Impact factor: 49.962

2.  Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.

Authors:  Suling Liu; Gabriela Dontu; Ilia D Mantle; Shivani Patel; Nam-shik Ahn; Kyle W Jackson; Prerna Suri; Max S Wicha
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

3.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

4.  Activation of mitochondrial apoptotic pathway in mantle cell lymphoma: high sensitivity to mitoxantrone in cases with functional DNA-damage response genes.

Authors:  Ana Ferrer; Silvia Marcé; Beatriz Bellosillo; Neus Villamor; Francesc Bosch; Armando López-Guillermo; Blanca Espinet; Francesc Solé; Emili Montserrat; Elias Campo; Dolors Colomer
Journal:  Oncogene       Date:  2004-11-25       Impact factor: 9.867

5.  Biology and plasticity of CD133+ hematopoietic stem cells.

Authors:  Rupert Handgretinger; Paul R Gordon; Thasia Leimig; Xiaohua Chen; Hans-Jorg Buhring; Dietrich Niethammer; Selim Kuci
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691

6.  Identification of a cancer stem cell in human brain tumors.

Authors:  Sheila K Singh; Ian D Clarke; Mizuhiko Terasaki; Victoria E Bonn; Cynthia Hawkins; Jeremy Squire; Peter B Dirks
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

Review 7.  Stem cells in normal breast development and breast cancer.

Authors:  Gabriela Dontu; Muhammad Al-Hajj; Wissam M Abdallah; Michael F Clarke; Max S Wicha
Journal:  Cell Prolif       Date:  2003-10       Impact factor: 6.831

Review 8.  Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.

Authors:  Giorgio Minotti; Pierantonio Menna; Emanuela Salvatorelli; Gaetano Cairo; Luca Gianni
Journal:  Pharmacol Rev       Date:  2004-06       Impact factor: 25.468

9.  Identification of human brain tumour initiating cells.

Authors:  Sheila K Singh; Cynthia Hawkins; Ian D Clarke; Jeremy A Squire; Jane Bayani; Takuichiro Hide; R Mark Henkelman; Michael D Cusimano; Peter B Dirks
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

Review 10.  Mammary stem cells, self-renewal pathways, and carcinogenesis.

Authors:  Suling Liu; Gabriela Dontu; Max S Wicha
Journal:  Breast Cancer Res       Date:  2005-03-30       Impact factor: 6.466

View more
  9 in total

1.  Direct interaction of β-catenin with nuclear ESM1 supports stemness of metastatic prostate cancer.

Authors:  Ke-Fan Pan; Wei-Jiunn Lee; Chun-Chi Chou; Yi-Chieh Yang; Yu-Chan Chang; Ming-Hsien Chien; Michael Hsiao; Kuo-Tai Hua
Journal:  EMBO J       Date:  2020-12-21       Impact factor: 11.598

2.  Transcriptional heterogeneity of stemness phenotypes in the ovarian epithelium.

Authors:  Lauren E Carter; David P Cook; Curtis W McCloskey; Melanie A Grondin; David A Landry; Tiffany Dang; Olga Collins; Lisa F Gamwell; Holly A Dempster; Barbara C Vanderhyden
Journal:  Commun Biol       Date:  2021-05-05

3.  Head and Neck Cancer Stem Cell-Enriched Spheroid Model for Anticancer Compound Screening.

Authors:  Larisa Goričan; Boris Gole; Uroš Potočnik
Journal:  Cells       Date:  2020-07-16       Impact factor: 6.600

Review 4.  The Molecular Basis of Different Approaches for the Study of Cancer Stem Cells and the Advantages and Disadvantages of a Three-Dimensional Culture.

Authors:  Danila Cianciosi; Johura Ansary; Tamara Y Forbes-Hernandez; Lucia Regolo; Denise Quinzi; Santos Gracia Villar; Eduardo Garcia Villena; Kilian Tutusaus Pifarre; José M Alvarez-Suarez; Maurizio Battino; Francesca Giampieri
Journal:  Molecules       Date:  2021-04-29       Impact factor: 4.411

5.  Metformin and ICG-001 Act Synergistically to Abrogate Cancer Stem Cells-Mediated Chemoresistance in Colorectal Cancer by Promoting Apoptosis and Autophagy.

Authors:  Souvick Roy; Yinghui Zhao; Yate-Ching Yuan; Ajay Goel
Journal:  Cancers (Basel)       Date:  2022-03-02       Impact factor: 6.639

Review 6.  Cancer stem cells and strategies for targeted drug delivery.

Authors:  Jin Cao; Shubhmita Bhatnagar; Jiawei Wang; Xueyong Qi; Swayam Prabha; Jayanth Panyam
Journal:  Drug Deliv Transl Res       Date:  2020-10-23       Impact factor: 5.671

7.  Intracellular Delivery of Anti-SMC2 Antibodies against Cancer Stem Cells.

Authors:  Sara Montero; Joaquin Seras-Franzoso; Fernanda Andrade; Francesc Martinez-Trucharte; Mireia Vilar-Hernández; Manuel Quesada; Helena Xandri; Diego Arango; Ibane Abasolo; Diana Rafael; Simo Schwartz
Journal:  Pharmaceutics       Date:  2020-02-21       Impact factor: 6.321

8.  A Marine Collagen-Based Biomimetic Hydrogel Recapitulates Cancer Stem Cell Niche and Enhances Progression and Chemoresistance in Human Ovarian Cancer.

Authors:  SooHyeon Moon; YeJin Ok; SeonYeong Hwang; Ye Seon Lim; Hye-Yoon Kim; Yong-Jin Na; Sik Yoon
Journal:  Mar Drugs       Date:  2020-09-29       Impact factor: 5.118

Review 9.  Exploring the Potential of Drug Response Assays for Precision Medicine in Ovarian Cancer.

Authors:  Tanya Singh; Adam S Neal; Neda A Moatamed; Sanaz Memarzadeh
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.